Search Results

The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes Systems That Drive Progress:  From assay tracking to data workflows, I design simple, scalable tools GPCR As the co-founder of Dr. GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field. Ready to Move Your GPCR Program Forward?

This partnership is designed to support the GPCR research community by expanding access to validated, Eurofins DiscoverX assay solutions are used throughout GPCR drug discovery workflows, from target identification GPCR and Eurofins DiscoverX aim to accelerate GPCR-targeted drug discovery by connecting scientists with platforms, deep pharmacological expertise, and expert-driven context that supports better experimental design GPCR empowers scientists and organizations advancing GPCR biology and GPCR-targeted drug discovery.

Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based Drug Discovery Conference  isn’t just another event—it’s where the frameworks shaping the next decade GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed. The pace of GPCR innovation is accelerating. Aside from his vast experience in drug development, not to mention his extensive publication record,

Fiona Marshall on structure-based GPCR drug discovery, the GABA-B heterodimer, the acetate that rewrote design as a productive strategy across GPCR families. Scientific Themes of the Conversation Structure-based GPCR drug design and the thermostabilization breakthrough drug design 18:47 Which GPCR families pharma is chasing now — and why 21:23 Why animal model validation stabilization and structure-based drug design.

Jacobson, Matteo Pavan Structure-Based Design of Modulators of Purinergic GPCRs <p class="font_8">Watch Now</p> Terry Kenakin Designing with Time: GPCR Ligand Kinetics <p class="font_8">Watch Now</p> Terry Biased Signaling & Allosteric Modulation Structure-Based Drug Design Innovation & Strategic Application The Masterclass is designed for GPCR researchers, pharmacologists, and drug discovery scientists working Experts explain how they think about pharmacological data, experimental design, and discovery challenges—insight

Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology , Bias, and Translational Drug Discovery This episode features Dr. How advanced assay design is essential for translating cell-based GPCR signals to therapeutic outcomes drug discovery. How integrating antibody-based modalities has expanded options for hard-to-drug GPCR targets.